Guardian Pharmacy Services (NYSE:GRDN) Downgraded by Wall Street Zen to “Hold”

Wall Street Zen downgraded shares of Guardian Pharmacy Services (NYSE:GRDN) from a buy rating to a hold rating in a research note published on Saturday morning,Wall Street Zen reports.

Other equities analysts also recently issued research reports about the company. Oppenheimer raised their target price on Guardian Pharmacy Services from $43.00 to $49.00 and gave the stock an “outperform” rating in a research report on Friday, August 7th. Truist Financial lifted their price objective on Guardian Pharmacy Services from $43.00 to $47.00 and gave the company a “buy” rating in a report on Wednesday, June 17th. Bank of America boosted their target price on shares of Guardian Pharmacy Services from $42.00 to $47.00 and gave the company a “buy” rating in a research note on Wednesday, June 17th. Finally, Weiss Ratings raised shares of Guardian Pharmacy Services from a “hold (c+)” rating to a “buy (b-)” rating in a report on Thursday, August 20th. Eight research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $43.83.

Guardian Pharmacy Services Stock Performance

Shares of Guardian Pharmacy Services stock opened at $45.02 on Friday. The firm’s 50-day simple moving average is $40.48 and its 200-day simple moving average is $38.88. Guardian Pharmacy Services has a twelve month low of $23.14 and a twelve month high of $48.33. The firm has a market cap of $2.24 billion, a P/E ratio of 43.71, a price-to-earnings-growth ratio of 2.33 and a beta of 0.06.

Guardian Pharmacy Services (NYSE:GRDN) last announced its quarterly earnings results on Thursday, August 6th. The company reported $0.29 EPS for the quarter, topping analysts’ consensus estimates of $0.26 by $0.03. Guardian Pharmacy Services had a net margin of 4.50% and a return on equity of 29.97%. The firm had revenue of $351.77 million during the quarter, compared to analysts’ expectations of $340.45 million. On average, equities analysts forecast that Guardian Pharmacy Services will post 1.19 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of GRDN. Clearstead Advisors LLC boosted its holdings in Guardian Pharmacy Services by 196.3% in the fourth quarter. Clearstead Advisors LLC now owns 2,628 shares of the company’s stock valued at $79,000 after acquiring an additional 1,741 shares during the last quarter. Elevation Point Wealth Partners LLC bought a new stake in Guardian Pharmacy Services during the 1st quarter worth about $253,000. Stephens Inc. AR bought a new stake in Guardian Pharmacy Services during the 1st quarter worth about $282,000. VIRGINIA RETIREMENT SYSTEMS ET Al acquired a new position in Guardian Pharmacy Services during the 2nd quarter valued at about $335,000. Finally, Arizona State Retirement System lifted its position in Guardian Pharmacy Services by 53.0% during the 2nd quarter. Arizona State Retirement System now owns 8,393 shares of the company’s stock valued at $351,000 after purchasing an additional 2,907 shares during the period.

Guardian Pharmacy Services Company Profile

Guardian Pharmacy Services, Inc is a long-term care pharmacy company that provides prescription medications and related pharmacy services to residents of assisted living communities, skilled nursing facilities, memory care centers and other institutional care settings.

The company’s services include medication dispensing and packaging, prescription delivery, medication management, pharmacy consulting and clinical support. Guardian works with care providers, residents and their families to help coordinate medication regimens, improve adherence and support the ongoing pharmacy needs of patients who may require complex or recurring treatments.

Guardian Pharmacy Services operates through a network of community-based pharmacies serving long-term care customers in multiple U.S.